Platelet aggregation inhibitors having high specificity for GPIIBIIIA
US5493007A · kind A · utility
35Cited by
12References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 1994 |
| Grant date | Feb 20, 1996 |
| Priority date | — |
| Expiry date | Sep 23, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A peptide containing the tripeptide recognition sequences RGD or KGD in a cycle and an exocyclic group bearing a positive charge is provided. The compound is provided in therapeutic form for administration to a mammal and exhibits high specificity and potency as a platelet aggregation inhibitor without undesireable side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.